These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 31250494)

  • 1. Commentary on Elliott et al. (2019): How stigma shapes overdose revival and possible avenues to disrupt it.
    Farrugia A
    Addiction; 2019 Aug; 114(8):1387-1388. PubMed ID: 31250494
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary on McAuley et al. (2017): Naloxone programs must reduce marginalization and improve access to comprehensive emergency care.
    M Orkin A; Buchman DZ
    Addiction; 2017 Feb; 112(2):309-310. PubMed ID: 28078707
    [No Abstract]   [Full Text] [Related]  

  • 3. Capsule Commentary on Binswanger et al., Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff.
    Jackson JL
    J Gen Intern Med; 2015 Dec; 30(12):1855. PubMed ID: 26286480
    [No Abstract]   [Full Text] [Related]  

  • 4. Naloxone Administration in US Emergency Departments, 2000-2011.
    Frank JW; Levy C; Calcaterra SL; Hoppe JA; Binswanger IA
    J Med Toxicol; 2016 Jun; 12(2):148-56. PubMed ID: 26621354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.
    O'Brien DC; Dabbs D; Dong K; Veugelers PJ; Hyshka E
    BMC Health Serv Res; 2019 Sep; 19(1):632. PubMed ID: 31488142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Naloxone by Emergency Medical Services during Opioid Drug Overdose Resuscitation Efforts.
    Sumner SA; Mercado-Crespo MC; Spelke MB; Paulozzi L; Sugerman DE; Hillis SD; Stanley C
    Prehosp Emerg Care; 2016; 20(2):220-5. PubMed ID: 26383533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary on Rege et al. (2018): Naloxone reports to US poison centers highlight overdose prevention opportunities.
    Oliva EM; Bounthavong M
    Addiction; 2018 Dec; 113(12):2316-2317. PubMed ID: 30345624
    [No Abstract]   [Full Text] [Related]  

  • 8. Science Over Stigma: Saving Lives--Implementation of Naloxone Use in the School Setting.
    King R
    NASN Sch Nurse; 2016 Mar; 31(2):96-101. PubMed ID: 26929211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary on Madah-Amiri et al. (2019): Beyond saturation.
    Bennett AS; Elliott L; Wolfson-Stofko B
    Addiction; 2019 Jan; 114(1):101-102. PubMed ID: 30520182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the front lines of the opioid epidemic: Rescue by naloxone.
    Skolnick P
    Eur J Pharmacol; 2018 Sep; 835():147-153. PubMed ID: 30092179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergency department naloxone distribution: a Rhode Island department of health, recovery community, and emergency department partnership to reduce opioid overdose deaths.
    Samuels E
    R I Med J (2013); 2014 Oct; 97(10):38-9. PubMed ID: 25271659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of provider attitudes toward #naloxone on Twitter.
    Haug NA; Bielenberg J; Linder SH; Lembke A
    Subst Abus; 2016; 37(1):35-41. PubMed ID: 26860229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary on McDonald et al. (2018): Intranasal naloxone-from the laboratory to the real world.
    Nielsen S; Larney S; Farrell M
    Addiction; 2018 Mar; 113(3):494-495. PubMed ID: 29423984
    [No Abstract]   [Full Text] [Related]  

  • 14. EMS naloxone administration as non-fatal opioid overdose surveillance: 6-year outcomes in Marion County, Indiana.
    Ray BR; Lowder EM; Kivisto AJ; Phalen P; Gil H
    Addiction; 2018 Dec; 113(12):2271-2279. PubMed ID: 30255531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of naloxone for overdose prevention to chronic pain patients.
    Coe MA; Walsh SL
    Prev Med; 2015 Nov; 80():41-3. PubMed ID: 26024850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary on Gjersing & Bretteville-Jensen (2015): EMS-treated opioid overdose--an important opportunity for saving lives.
    Dailey M
    Addiction; 2015 Nov; 110(11):1775-6. PubMed ID: 26471158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.
    Mueller SR; Walley AY; Calcaterra SL; Glanz JM; Binswanger IA
    Subst Abus; 2015; 36(2):240-53. PubMed ID: 25774771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies and policies to address the opioid epidemic: A case study of Ohio.
    Penm J; MacKinnon NJ; Boone JM; Ciaccia A; McNamee C; Winstanley EL
    J Am Pharm Assoc (2003); 2017; 57(2S):S148-S153. PubMed ID: 28189539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid overdose prevention and naloxone rescue kits: what we know and what we don't know.
    Kerensky T; Walley AY
    Addict Sci Clin Pract; 2017 Jan; 12(1):4. PubMed ID: 28061909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engaging Law Enforcement in Overdose Reversal Initiatives: Authorization and Liability for Naloxone Administration.
    Davis CS; Carr D; Southwell JK; Beletsky L
    Am J Public Health; 2015 Aug; 105(8):1530-7. PubMed ID: 26066921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.